ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 115 filers reported holding ARATANA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $58,000 | -54.7% | 10,000 | -66.7% | 0.01% | -61.5% |
Q2 2018 | $128,000 | -68.1% | 30,000 | -67.0% | 0.01% | -68.3% |
Q1 2018 | $401,000 | -24.5% | 91,000 | -9.9% | 0.04% | -40.6% |
Q4 2017 | $531,000 | +22.1% | 101,000 | +42.3% | 0.07% | +21.1% |
Q3 2017 | $435,000 | -25.8% | 71,000 | -12.3% | 0.06% | -26.0% |
Q2 2017 | $586,000 | – | 81,000 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,093,845 | $32,685,000 | 11.00% |
Broadfin Capital, LLC | 1,634,870 | $25,520,000 | 1.26% |
MARXE AUSTIN W & GREENHOUSE DAVID M | 600,000 | $9,366,000 | 1.19% |
Grandeur Peak Global Advisors, LLC | 179,900 | $2,808,000 | 0.60% |
First Light Asset Management, LLC | 52,234 | $815,000 | 0.55% |
Granite Point Capital Management, L.P. | 50,000 | $781,000 | 0.54% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 788,904 | $12,315,000 | 0.50% |
ALYDAR PARTNERS LLC | 180,000 | $2,810,000 | 0.24% |
CHARTWELL INVESTMENT PARTNERS, LLC | 431,444 | $6,735,000 | 0.14% |
Nicholas Investment Partners, LP | 141,127 | $2,203,000 | 0.13% |